Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology

1984/01/01 by E. J. Ari�ns · 22 citations
Chemistry · Medicine · Pharmacology, Toxicology and Pharmaceutics · #Analytical Chemistry and Chromatography #Cancer Treatment and Pharmacology #Pharmacogenetics and Drug Metabolism

paper · doi:10.1007/bf00541922

crossref issued 1984/01/01 · crossref published 1984/01/01 · crossref published-print 1984/01/01 · openalex publication_date 1984/01/01 · crossref created 2004/11/18 · openalex created_date 2016/06/24 · crossref deposited 2023/04/30 · crossref indexed 2026/07/06 · openalex updated_date 2026/07/23

Cited by

• The FDA perspective on the development of stereoisomers
• Stereochemical implications of hybrid and pseudo‐hybrid drugs. Part III
• Stereoselectivity in the Action of Drugs
• Drug Chirality and its Clinical Significance
• Stereochemistry: A source of problems in medicinal chemistry
• Importance of stereospecific bionalytical monitoring in drug development
• Molecular Asymmetry and Its Pharmacological Consequences
• Racemic mixtures and single stereoisomers: Industrial concerns and issues in drug development
• Methods for the analysis of enantiomers of racemic drugs application to pharmacological and pharmacokinetic studies
• Chirality in bioactive agents and its pitfalls
• Implications of the Neglect of Stereochemistry in Pharmacokinetics and Clinical Pharmacology
• Importance of Drug Enantiomers in Clinical Pharmacology
• The relevance of chirality to the study of biological activity
• Chapter 34. Significance of Drug Stereochemistry in Modern Pharmaceutical Research and Development
• Stereoselectivity of bioactive xenobiotics
• Racemic Therapeutics—Problems all Along the Line
• Molecular Chirality: Language, History, and Significance
• Etodolac Clinical Pharmacokinetics
• Entrevista Rigoberta Menchu
• Chiral drugs [wikipedia]
• Enantiopure drug [wikipedia]
• Molecular configuration [wikipedia]